CD8A and breast cancer: Furthermore, two studies analyzing mixed trial and/or clinical cohorts (of almost 6000 and 1400 ER-positive tumors, respectively) reported that higher levels of intratumoral CD8+ TILs were associated with a significant reduction in BC-specific survival80,86.